About 100 reports

  • 3.2 RISK FACTORS AND COMORBIDITIES
  • Risk Factors and Comorbidities for NHL
  • Lymphoma
  • Germany
  • Japan
  • Spain
  • Forecast

CURRENT IMMUNE MEDIATED DISEASE FOCUS MORE ON HIV/ AIDS, TUBERCULOSIS, PNEUMONIA, ENTERIC DISEASES AND MALARIA.

  • Lymphoma
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb Company

AIDS MALIGNANCY CONSORTIUM (AMC) ##.

  • Lymphoma
  • Demand
  • Market Size
  • AbbVie Inc.
  • Seattle Genetics, Inc.
  • Risk Factors and Comorbidities for NHL
  • Lymphoma
  • AbbVie Inc.
  • GlobalData's company
  • Novartis AG
  • Roche Group
  • Epidemiologist Insight

The literature suggests that the rise of infections, mainly HIV and AIDS that caused immunosuppression during these periods, have likely triggered the historical trend noted (Morton et al., 2006).

  • Lymphoma
  • Europe
  • Japan
  • Celgene Corporation
  • Roche Group
  • Epidemiologist Insight

The literature suggests that the rise of infections, mainly HIV and AIDS that caused immunosuppression during these periods, have likely triggered the historical trend noted (Morton et al., 2006).

  • Lymphoma
  • Europe
  • Celgene Corporation
  • Pfizer Inc.
  • Roche Group
  • Epidemiologist Insight

The literature suggests that the rise of infections, mainly HIV and AIDS that caused immunosuppression during these periods, have likely triggered the historical trend noted (Morton et al., 2006).

  • Lymphoma
  • Europe
  • Japan
  • Biogen Idec Inc.
  • Roche Group

Disease Subarachnoid Hemorrhage GVHD Sickle Cell Disease HIV / AIDS ## ##.

  • Lymphoma
  • United States
  • Mirati Therapeutics, Inc.
  • Novartis AG
  • Pharmacyclics, Inc.

UNDER THE AGREEMENT, THE PARTNERS AGREED TO DEVELOP NOVEL DRUGS TO TREAT CANCER, HIV / AIDS AND AUTOIMMUNE DISEASE BY LEVERAGING THE TECHNOLOGIES OF BOTH PLAYERS.

  • Lymphoma
  • United States
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.
  • Novartis AG

These groups could include patients receiving an organ transplant as well as HIV and AIDs patients.

  • Cancer
  • Lymphoma
  • Pathology
  • Europe

A META-ANALYSIS OF THE INCIDENCE OF NON-AIDS CANCERS IN HIV-INFECTED INDIVIDUALS.

  • Lymphoma
  • Affimed Therapeutics AG
  • Incyte Corporation
  • Merck & Co., Inc.
  • Seattle Genetics, Inc.

A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.

  • Cancer
  • Epidemiology
  • Lymphoma
  • Japan
  • Forecast

THIS FEATURE CAN BE USED FOR THE TREATMENT OF PATHOLOGIES SUCH AS HIV/ AIDS MORE THAN ## YEARS AGO, THE TRANSCRIPTION FACTORS WERE OBTAINED FROM THE EGG PROTEIN OF XENOPUSLAEVIS.

  • Lymphoma
  • United States
  • Cellectis S.A.
  • Juno Therapeutics Inc.
  • Kite Pharma, Inc.

TUBERCULOSIS, LEPROSY, MALARIA, HIV/ AIDS, PULMONARY DISEASES, ALZHEIMER' S DISEASE AND CROHN' S DISEASE) ARE BEING AIMED FOR TREATMENT WITH COMBINATION THERAPIES.

  • Lymphoma
  • United States
  • Agenus Inc.
  • Incyte Corporation
  • Merck & Co., Inc.
  • selinexor
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017 (CONTD..1), H2 2017

HIV) Infections (AIDS), Human Papillomavirus (HPV) Associated Cancer, Influenza A Virus, H##N## Subtype Infections, Influenza A Virus, H##N## Subtype Infections, Influenza A Virus, H##N## Subtype Infections, Leiomyosarcoma, Liposarcoma, Lymphoma, Mantle Cell Lymphoma, Melanoma, Metastati

  • Lymphoma
  • United States
  • World
  • Product Initiative
  • Karyopharm Therapeutics Inc.
  • DORMANT PRODUCTS, H1 2017 (CONTD..1), H1 2017
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

HIV) Infections (AIDS), Human Papillomavirus (HPV) Associated Cancer, Influenzavirus A Infections, Leiomyosarcoma, Leukemias, Liposarcoma, Lymphoma, Mantle Cell Lymphoma, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Multiple Sclerosis, Neuroendocrine Tumors, Non-Hodgkin

  • Lymphoma
  • United States
  • World
  • Product Initiative
  • Karyopharm Therapeutics Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017 (CONTD..1), H2 2017
  • PIPELINE BY CHIPSCREEN BIOSCIENCES LTD, H2 2017
  • Breast Cancer
  • Lymphoma
  • United States
  • Product Initiative
  • Syndax Pharmaceuticals, Inc.
  • HIV / AIDS
  • PRODUCTS UNDER INVESTIGATION BY UNIVERSITIES/INSTITUTES, H1 2016
  • Cancer
  • Cancer Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Merck & Co., Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PIPELINE BY CHIPSCREEN BIOSCIENCES LTD, H2 2017
  • Lymphoma
  • Pharmaceutical
  • China
  • Product Initiative
  • Chipscreen Biosciences Ltd
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017 (CONTD..2), H2 2017
  • PIPELINE BY CHIPSCREEN BIOSCIENCES LTD, H2 2017
  • Cancer
  • Lymphoma
  • United States
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H1 2017
  • PIPELINE BY CHIPSCREEN BIOSCIENCES LTD, H1 2017
  • Lymphoma
  • China
  • Japan
  • Product Initiative
  • Chipscreen Biosciences Ltd
  • Target
  • Official Title
  • Cell Therapy
  • Lymphoma
  • United States
  • World
  • GlaxoSmithKline plc
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2016
  • PIPELINE BY ALTOR BIOSCIENCE CORP, H2 2016

The preliminary results from these collaborations are very encouraging and indicate that ALT-## has substantial potency against a variety of solid tumors as well as HIV infection in experimental models.

  • Cancer
  • Interleukin
  • Lymphoma
  • Therapy
  • Altor BioScience Corporation
  • Clinical Trial profile. 30 Trial Title
  • Clinical Trial profile. 49 Trial Title
  • HIV AIDS
  • Hospital
  • Lymphoma
  • World
  • Product Initiative
  • EWING SARCOMA
  • DIFFUSE LARGE B-CELL LYMPHOMA
  • Lymphoma
  • Renal Cancer
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company

Descovy does not cure HIV infection or AIDS.

  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • United States
  • Gilead Sciences, Inc.
  • Clinical Trial profile. 39 Trial Title
  • Official Title
  • HIV AIDS
  • Hospital
  • Lymphoma
  • World
  • Product Initiative
  • Lymphocytic Leukemia (CLL),Waldenstrom Macroglobulinemia
  • Gilead Sciences, Inc. - Dormant Projects
  • Antiviral
  • Lymphoma
  • Research And Development
  • United States
  • Gilead Sciences, Inc.

Fred Hutchinson Cancer Research Center (Fred Hutchinson), a subsidiary of National Comprehensive Cancer Network, is a nonprofit organization which conducts research on the prevention, diagnose and treatment of cancer, HIV/ AIDS and other life threatening diseases.

  • Lymphoma
  • Therapy
  • United States
  • Company Operations
  • Juno Therapeutics Inc.
  • ESCHERICHIA COLI INFECTIONS
  • Digestive System Disorder
  • Hospital
  • Lymphoma
  • Therapy
  • MediciNova, Inc.